9 Further information on the emergence, spread and prevention of resistance to antimalarials is provided in Annex 6. from Peru. P. vivax remains sensitive to chloroquine in South-East Asia, the Indian subcontinent, the Korean peninsula, the Middle East, north-east Africa, and most of South and Central America.
Resistance has arisen to all classes of antimalarials except, as yet, to the artemisinin derivatives. This has increased the global malaria burden and is a major threat to malaria control. Widespread and indiscriminate use of anti-malarials places a strong selective pressure on malaria parasites to develop high levels of resistance. Resistance can be prevented, or its onset slowed considerably, by combining antimalarials with different mechanisms of action and ensuring very high cure rates through full adherence to correct dose regimens.